Week Ending July 6, 2021

Most People With Hepatitis C Have Improved Liver Function After Treatment
“While a majority of people with hepatitis C and liver cirrhosis have better liver function after antiviral therapy, some people with prior liver failure develop worse cirrhosis, according to study results published in BMC Infectious Diseases.”

Hepatitis C Treatment-As-Prevention Reduces Virus Incidence In a Prison Setting
“In a study on the effectiveness of hepatis C virus (HCV) treatment-as-prevention, direct-acting antiviral treatment was associated with reduced incidence of HCV. These study results were published in The Lancet Gastroenterology & Hepatology.”

Resmetirom Appears to Cut Liver Fat and Improve Fibrosis
“The experimental drug resmetirom appeared to reduce liver fat and fibrosis based on changes in biomarkers and noninvasive imaging in people with fatty liver disease, according to results from a Phase III study presented last week at the International Liver Congress. But these findings will need to be confirmed in a controlled trial that includes liver biopsies.”

What you should know about Hep C
“Up to 5.3 million Americans have chronic Hepatitis C (HCV) infection according to the Centers for Disease Control (CDC).”